Table 9.

Trials evaluating motexafin gadolinium (MGd) as a radiosensitizer, sorted by publication year

Author	Year	Agent	Dose	n	Radiation regimen	Results
Ford et al. [67]	2007	Motexafin Gadolinium	10–22 × 4–5.2 mg/kg/day	33	59.4 Gy in 33 fractions	MTD: 5 mg/kg/day Median OS: 16.1 months
Bachman et al. [70]	2015	Motexafin Gadolinium	3–5 mg/kg daily pre RT	118	60 Gy in 30 fractions	MTD MGd: 5 mg/kg/day Median OS: 15.6 months RT + MGd + TMZ was well tolerated
		+ TMZ	75 mg/m2/day

n = number of patients included (number of patients with glioblastoma in parentheses if multiple entities were included)